LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Home・Listă Acțiuni・Pfizer

Pfizer

Închisă

SectorSănătate

25.69 1.38

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

25.35

Maxim

25.98

Indicatori cheie
By Trading Economics
Venit	4.3B 2.7B
Vânzări	-3.1B 14B
P/E Medie Sector	19.565 49.888
EPS	0.47
Randament dividend	6.57
Marjă de profit	18.656
Angajați	75,000
EBITDA	4.5B 5.2B

Recomandări
By TipRanks
Recomandări	Neutru
Prognoză pe 12 luni	+15.11% upside

Dividende
By Dow Jones
Randament dividend Medie Sector	6.57% 2.38%
Următoarele câștiguri	4 aug. 2026
Data viitoare de dividende	12 iun. 2026
Următoarea dată ex-dividende	24 iul. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-3.5B 146B
Deschiderea anterioară	24.31
Închiderea anterioară	25.69

Sentimentul știrilor

By Acuity

45%

55%

144 / 344 Clasament în Healthcare

Pfizer Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

5 mai 2026, 11:31 UTC

Câștiguri

Pfizer 1Q Revenue Rises But Profit Falls Amid Boosted R&D Spending

5 mai 2026, 18:12 UTC

Câștiguri

BioNTech to Slash 22% of Workforce as Losses Widen. The Stock Falls. -- Barrons.com

5 mai 2026, 13:54 UTC

Câștiguri

BioNTech to Slash 25% of Workforce as Losses Widen. The Stock Falls. -- Barrons.com

5 mai 2026, 12:35 UTC

Câștiguri

Pfizer Posts Better-Than-Expected Revenue, Profit -- WSJ

5 mai 2026, 11:06 UTC

Câștiguri

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates -- Barrons.com

5 mai 2026, 10:47 UTC

Câștiguri

Pfizer: Current Financial Guidance Doesn't Anticipate Any Stock Buybacks in 2026 >PFE

5 mai 2026, 10:47 UTC

Câștiguri

Pfizer Still Sees 2026 Adjusted R&D Expenses $10.5B-$11.5B >PFE

5 mai 2026, 10:46 UTC

Câștiguri

Pfizer 1Q Revenue of Launched, Acquired Products Rose 22% Operationally >PFE

5 mai 2026, 10:46 UTC

Câștiguri

Pfizer 1Q Revenue Rose 7% Operationally Excluding Contributions From Comirnaty, Paxlovid >PFE

5 mai 2026, 10:45 UTC

Câștiguri

Pfizer Reaffirms 2026 Guidance >PFE

5 mai 2026, 10:45 UTC

Câștiguri

Pfizer Sees FY Rev $59.5B-$62.5B >PFE

5 mai 2026, 10:45 UTC

Câștiguri

Pfizer Sees FY Adj EPS $2.80-Adj EPS $3.00 >PFE

5 mai 2026, 10:45 UTC

Câștiguri

Pfizer 1Q Rev $14.5B >PFE

5 mai 2026, 10:45 UTC

Câștiguri

Pfizer 1Q EPS 47c >PFE

5 mai 2026, 10:45 UTC

Câștiguri

Pfizer 1Q Net $2.69B >PFE

5 mai 2026, 10:45 UTC

Câștiguri

Pfizer 1Q Adj EPS 75c >PFE

5 mai 2026, 10:36 UTC

Acțiuni populare

Stocks to Watch: Palantir, HSBC, Intel, AMD -- WSJ

23 apr. 2026, 21:48 UTC

Achiziții, Fuziuni, Preluări

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

1 apr. 2026, 20:07 UTC

Achiziții, Fuziuni, Preluări

Why 2026 Is Biotech's Comeback Year -- Barrons.com

11 mar. 2026, 11:02 UTC

Market Talk

Sanofi, Regeneron's Eczema Drug Might Face Competition From Pfizer -- Market Talk

10 mar. 2026, 12:50 UTC

Câștiguri

BioNTech Stock Plunges 17% After Earnings. Why the Drugmaker Faces a Perfect Storm. -- Barrons.com

10 mar. 2026, 11:18 UTC

Câștiguri

BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock. -- Barrons.com

9 mar. 2026, 09:43 UTC

Acțiuni populare

Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer -- WSJ

10 feb. 2026, 21:51 UTC

Câștiguri

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 feb. 2026, 21:17 UTC

Câștiguri

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

3 feb. 2026, 21:36 UTC

Câștiguri

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 feb. 2026, 19:56 UTC

Câștiguri

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 feb. 2026, 19:46 UTC

Câștiguri

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 feb. 2026, 17:35 UTC

Câștiguri

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 feb. 2026, 17:30 UTC

Câștiguri

These Stocks Are Today's Movers: Palantir, PayPal, Novo Nordisk, Pfizer, Merck, AMD, Gartner, and More -- Barrons.com

Comparație

Modificare preț

Pfizer Așteptări

Obiectiv de preț

By TipRanks

15.11% sus

Prognoză pe 12 luni

Medie 29.17 USD 15.11%

Maxim 36 USD

Minim 25 USD

În baza a 22 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPfizer - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

22 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 22 analiști care au acordat evaluări ale acțiunilor Pfizer - Dist în ultimele 3 luni.

Sentiment

By Acuity

144 / 344 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.